Skip to main content
MDBH
NASDAQ Finance

MDB Capital Q3 Loss Widens to $16.4M on $9.86M eXoZymes Impairment

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Capital Markets Stocks · Financial
Sentiment info
Negative
Importance info
7
Price
$1.504
Mkt Cap
$15.699M
52W Low
$0.89
52W High
$4.8
52W Position info
69% above low
Off High info
69% below high
Rel. Volume info
1.5× avg
Market data snapshot near publication time

MDBH sits 69% above its 52-week low of $0.89.

Summary

MDB Capital's Q3 loss widened to $16.4M, driven by a $9.86M non-cash impairment of its eXoZymes stake, while cash fell to $8.3M after $6.7M of nine-month operating burn.


Key Events · Earnings and Guidance · MDBH

  • Q3 Loss Widens on Impairment

    Net loss attributable to MDB was $16.4M for the three months ended September 30, 2026, versus $4.7M a year earlier, including a $9.86M impairment of the eXoZymes equity method investment.

  • Nine-Month Loss Nearly Doubles

    Net loss for the nine months reached $32.5M versus $19.5M in 2025, with $13.2M of equity in loss of the eXoZymes investee and $5.9M of unrealized losses on broker-dealer securities.

  • Cash Falls to $8.3M

    Cash and equivalents were $8.3M at September 30, 2026, down from $13.2M at December 31, 2025, after $6.7M of operating cash burn; working capital fell $5.7M to $9.9M.

  • Fee Income Up 54%

    Nine-month fee income rose to $3.3M from $2.1M, plus $892K of related-party fee income from eXoZymes, though Q3 fee income was only $333K.


Analysis · MDBH · Finance

The quarter's loss more than tripled year over year, and almost all of the damage is a non-cash write-down: MDB marked its eXoZymes stake down by $9.86M after the shares kept trading below cost. Strip that out and the operating business is still losing money, but the broker-dealer is generating more fees — nine-month fee income rose 54% to $3.3M. The real constraint is cash: $8.3M on hand against $6.7M burned in nine months leaves a thin runway, and the company has no debt drawn on its $2.0M revolver to fall back on.

How filings like this one have moved

In the 30 days to Nov 12, 2026, 37% of the 3595 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, MDBH was trading at $1.50 on NASDAQ in the Finance sector, with a market capitalization of approximately $15.7M. The 52-week trading range was $0.89 to $4.80. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

MDBH - Latest Insights

MDBH
Aug 13, 2026, 4:05 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $3.02
Real-time Price: $1.50 info
Change: -$1.52 (-50%) info
Market Cap: $15.699M info
MDBH
May 14, 2026, 4:09 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $3.21
Real-time Price: $1.50 info
Change: -$1.71 (-53%) info
Market Cap: $15.699M info
MDBH
Mar 31, 2026, 11:26 AM EDT
Filing Type: 10-K
Importance Score:
9
Price at Filing: $2.93
Real-time Price: $1.50 info
Change: -$1.43 (-49%) info
Market Cap: $15.699M info
MDBH
Feb 02, 2026, 5:16 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $3.20
Real-time Price: $1.50 info
Change: -$1.70 (-53%) info
Market Cap: $15.699M info